Poll: docs say don't take away CME support

Share this article:
A poll of 268 physicians found that 92% disagree with an American Medical Association (AMA) committee's call to end commercial support of CME.

Respondents to the online poll, by med ed provider Pri-Med, expressed concern that a ban on commercial support would make it more expensive for them to receive CME and that the quality of CME would decrease, making it harder for physicians to stay up to date and ultimately impacting patient care.
“I don't receive CME reimbursement from my employer,” said one respondent. “Any subsidy is very beneficial to me.”

Last month, the AMA's Council on Ethical and Judicial Affairs, which makes ethics policy for the society, issued a report arguing that physicians and institutions of medicine should not accept commercial support for CME except for narrow technical training on new diagnostic or therapeutic devices and techniques. The report's recommendations will be taken up by the AMA House of Delegates at its annual meeting, June 14-18 in Chicago.
Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.